Ascentage Pharma Group International AAPG Insider Ownership

NASDAQ AAPG
$17.60 +0.24 (+1.38%)
As of: Sep 4, 2026 · 10:13 AM EDT

Insider Holdings by Owner

3.20Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
—
share count not reported for this filer set
Shares Held by Insiders
1.60Mn
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
—
not reported
Direct Holdings
1.19Mn
Indirect: 405.28K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
2
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

Ascentage Pharma Group International's three largest insider shareholders as of August 29, 2026 are Yifan Zhai (Chief Medical Officer, 1.60Mn shares), Dajun Yang (Chairman And Ceo, 1.60Mn shares).

Form 4 Holdings

Insiders Holding AAPG

Insiders 2
Shares held 3.20Mn
Of outstanding —
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Dajun Yang Chairman And Ceo 1,193,569 405,280 1,598,849 50.0% 22 May, 2026
2 Yifan Zhai Chief Medical Officer 405,280 1,193,569 1,598,849 50.0% 22 May, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

25 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
21 May, 2026 Yifan Zhai Chief Medical Officer Acquired M 92,746 $0.00 $0 405,280 Direct
21 May, 2026 Dajun Yang Chairman And Ceo Acquired M 95,575 $0.00 $0 1,193,569 Direct
21 May, 2026 Dajun Yang Chairman And Ceo Acquired M 92,746 $0.00 $0 405,280 Indirect
21 May, 2026 Yifan Zhai Chief Medical Officer Acquired M 95,575 $0.00 $0 1,193,569 Indirect
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 103,365 $0.00 $0 103,365 Direct
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 95,575 $0.00 $0 95,575 Direct
21 May, 2026 Dajun Yang Chairman And Ceo Disposed M 95,575 $0.00 $0 0 Direct
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 214,999 $0.00 $0 214,999 Direct
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 298,195 $0.00 $0 0 Direct
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 214,988 $0.00 $0 214,988 Direct
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 298,194 $0.00 $0 298,194 Direct
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 103,364 $0.00 $0 103,364 Direct
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 92,746 $0.00 $0 92,746 Direct
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 103,365 $0.00 $0 103,365 Indirect
21 May, 2026 Yifan Zhai Chief Medical Officer Disposed M 92,746 $0.00 $0 0 Direct
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 214,999 $0.00 $0 214,999 Indirect
20 May, 2026 Yifan Zhai Chief Medical Officer Acquired A 95,575 $0.00 $0 95,575 Indirect
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 214,988 $0.00 $0 214,988 Indirect
21 May, 2026 Yifan Zhai Chief Medical Officer Disposed M 95,575 $0.00 $0 0 Indirect
20 May, 2026 Dajun Yang Chairman And Ceo Acquired A 103,364 $0.00 $0 103,364 Indirect